These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of delayed activated charcoal on acetaminophen concentration after simulated overdose of oxycodone and acetaminophen. Mullins M, Froelke BR, Rivera MR. Clin Toxicol (Phila); 2009 Feb; 47(2):112-5. PubMed ID: 18787997 [Abstract] [Full Text] [Related]
4. Comparative pharmacokinetics of Panadol Extend and immediate-release paracetamol in a simulated overdose model. Tan C, Graudins A. Emerg Med Australas; 2006 Aug; 18(4):398-403. PubMed ID: 16842311 [Abstract] [Full Text] [Related]
5. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers. Darwish M, Tempero K, Kirby M, Thompson J. Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093 [Abstract] [Full Text] [Related]
6. Oral absorption kinetics of levetiracetam: the effect of mixing with food or enteral nutrition formulas. Fay MA, Sheth RD, Gidal BE. Clin Ther; 2005 May; 27(5):594-8. PubMed ID: 15978308 [Abstract] [Full Text] [Related]
8. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers. Darwish M, Kirby M, Robertson P, Tracewell W, Jiang JG. Clin Ther; 2006 May; 28(5):707-14. PubMed ID: 16861092 [Abstract] [Full Text] [Related]
9. Treatment of acetaminophen ingestion with a superactivated charcoal-cola mixture. Rangan C, Nordt SP, Hamilton R, Ingels M, Clark RF. Ann Emerg Med; 2001 Jan; 37(1):55-8. PubMed ID: 11145772 [Abstract] [Full Text] [Related]
10. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs. Lapatto-Reiniluoto O, Kivistö KT, Neuvonen PJ. Clin Pharmacol Ther; 2001 Sep; 70(3):255-60. PubMed ID: 11557913 [Abstract] [Full Text] [Related]
11. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults. Swearingen D, Pennick M, Shojaei A, Lyne A, Fiske K. Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285 [Abstract] [Full Text] [Related]
12. Pharmacokinetic interaction studies of atosiban with labetalol or betamethasone in healthy female volunteers. Rasmussen BB, Larsen LS, Senderovitz T. BJOG; 2005 Nov; 112(11):1492-9. PubMed ID: 16225568 [Abstract] [Full Text] [Related]
17. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study. Di Girolamo G, Keller GA, de Los Santos AR, Schere D, Gonzalez CD. Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789 [Abstract] [Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease. Smith WB, Dowell JA, Pratt RD. Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688 [Abstract] [Full Text] [Related]
20. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers. Rhim SY, Park JH, Park YS, Lee MH, Kim DS, Shaw LM, Yang SC, Kang JS. Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104 [Abstract] [Full Text] [Related] Page: [Next] [New Search]